KRYS
Krystal Biotech, Inc.
Nasdaq: KRYS · Pittsburgh, PA · Healthcare
$358.24-13.23 (-3.56%)Closed
Market Cap$10.60B
Cash$427.7Mmost recent
Runwayprofitable
P/E (TTM)52.4EPS $6.84
52-Wk Range$137.46 – $378.15
Avg Volume329.4K3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$358.24+92.5%
Pipeline
Drug candidates sponsored by KRYS · ClinicalTrials.gov
Couldn't load pipeline. ClinicalTrials.gov or the backend may be unavailable.
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for KRYS. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.